Last updated: April 18, 2024
Sponsor: Seattle Children's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Fetoscopic laser ablation
Clinical Study ID
NCT05008744
00003168
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Single placenta (Monochorionic)
- Polyhydramnios present in recipient twin (Greater than 8 cm maximum vertical pocketbelow 20 weeks and greater than a 10 cm pocket for greater than 20 weeks gestationalage)
- Oligohydramnios present in donor twin (Less than 2 cm maximum vertical pocket)
- Prominent bladder in the recipient/ non-filling bladder in the donor
- Thin dividing membrane
Exclusion
Exclusion Criteria:
- Patients unwilling to participate in the study or to be followed up
- Presence of major congenital anomalies incompatible with survival
- Active pre-term labor Ruptured membranes
- Chorioamnionitis
- Vaginal bleeding
Study Design
Total Participants: 2000
Treatment Group(s): 1
Primary Treatment: Fetoscopic laser ablation
Phase:
Study Start date:
October 01, 2021
Estimated Completion Date:
October 01, 2031
Study Description
Connect with a study center
Seattle Childrens Hospital
Seattle, Washington 98015
United StatesActive - Recruiting
University of Washington
Seattle, Washington 98195
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.